Cost of medical services in older patients with heart failure: Those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: The heart failure home care trial

Ozlem Z. Soran, Arthur M. Feldman, Ileana L. Pina, Gervasio A. Lamas, Sheryl F. Kelsey, Faith Selzer, John Pilotte, Judith R. Lave

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Prior studies suggest that disease management programs may be effective in improving clinical and economic outcomes in patients with heart failure. Whether these types of programs can lower health care cost and be adapted to the primary care setting is unknown. This study was designed to assess the impact of a home-based disease management program, the Alere DayLink HF Monitoring System (HFMS), on the clinical and economic outcomes of Medicare beneficiaries recently hospitalized for heart failure who received the care from a community-based primary care practitioner. Methods and Results: The Heart Failure Home Care trial was a multicenter, randomized, controlled trial of sophisticated, monitoring of heart failure patients with an interactive program versus standard heart failure care with enhanced patient education and follow-up (SC) in Medicare-eligible patients. The study endpoints included cardiovascular death or rehospitalization for heart failure, length of hospital stay, total patient cost, and cost to Medicare at 6 months of enrollment. A total of 315 patients age ≥65 years old were randomized: 160 to the HFMS and 155 to SC. There were no significant statistical differences between the groups in regards to 6-month cardiac mortality, rehospitalizations for heart failure, or length of hospital stay. Of those, 304 patients had their Medicare data available. The information from the Medicare claims data was used to determine the cost. Information from the trial was used to determine costs of out-patient drugs and the interventions. The 6-month mean Medicare costs were estimated to be $17,837 and $13,886 for the HFMS and the SC groups, respectively. We found that overall medical costs of medicare patients were significantly higher for patients who were randomized to the HFMS arm than they were for the patients randomized to the SC arm. Conclusions: Our study results suggest that enhanced patient education and follow-up is as successful as a sophisticated home monitoring device with an interactive program and less costly in patients who are elderly and receive the care from a community-based primary care practitioner.

Original languageEnglish (US)
Pages (from-to)859-866
Number of pages8
JournalJournal of Cardiac Failure
Volume16
Issue number11
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Home Care Services
Heart Failure
Medicare
Costs and Cost Analysis
Length of Stay
Primary Health Care
Patient Education
Disease Management
Economics
Health Care Costs
Outpatients
Randomized Controlled Trials
Equipment and Supplies
Mortality

Keywords

  • cost
  • disease management programs
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cost of medical services in older patients with heart failure : Those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: The heart failure home care trial. / Soran, Ozlem Z.; Feldman, Arthur M.; Pina, Ileana L.; Lamas, Gervasio A.; Kelsey, Sheryl F.; Selzer, Faith; Pilotte, John; Lave, Judith R.

In: Journal of Cardiac Failure, Vol. 16, No. 11, 11.2010, p. 859-866.

Research output: Contribution to journalArticle

Soran, Ozlem Z. ; Feldman, Arthur M. ; Pina, Ileana L. ; Lamas, Gervasio A. ; Kelsey, Sheryl F. ; Selzer, Faith ; Pilotte, John ; Lave, Judith R. / Cost of medical services in older patients with heart failure : Those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: The heart failure home care trial. In: Journal of Cardiac Failure. 2010 ; Vol. 16, No. 11. pp. 859-866.
@article{fd34c6d5f5df405aaae4fabec85c7129,
title = "Cost of medical services in older patients with heart failure: Those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: The heart failure home care trial",
abstract = "Background: Prior studies suggest that disease management programs may be effective in improving clinical and economic outcomes in patients with heart failure. Whether these types of programs can lower health care cost and be adapted to the primary care setting is unknown. This study was designed to assess the impact of a home-based disease management program, the Alere DayLink HF Monitoring System (HFMS), on the clinical and economic outcomes of Medicare beneficiaries recently hospitalized for heart failure who received the care from a community-based primary care practitioner. Methods and Results: The Heart Failure Home Care trial was a multicenter, randomized, controlled trial of sophisticated, monitoring of heart failure patients with an interactive program versus standard heart failure care with enhanced patient education and follow-up (SC) in Medicare-eligible patients. The study endpoints included cardiovascular death or rehospitalization for heart failure, length of hospital stay, total patient cost, and cost to Medicare at 6 months of enrollment. A total of 315 patients age ≥65 years old were randomized: 160 to the HFMS and 155 to SC. There were no significant statistical differences between the groups in regards to 6-month cardiac mortality, rehospitalizations for heart failure, or length of hospital stay. Of those, 304 patients had their Medicare data available. The information from the Medicare claims data was used to determine the cost. Information from the trial was used to determine costs of out-patient drugs and the interventions. The 6-month mean Medicare costs were estimated to be $17,837 and $13,886 for the HFMS and the SC groups, respectively. We found that overall medical costs of medicare patients were significantly higher for patients who were randomized to the HFMS arm than they were for the patients randomized to the SC arm. Conclusions: Our study results suggest that enhanced patient education and follow-up is as successful as a sophisticated home monitoring device with an interactive program and less costly in patients who are elderly and receive the care from a community-based primary care practitioner.",
keywords = "cost, disease management programs, Heart failure",
author = "Soran, {Ozlem Z.} and Feldman, {Arthur M.} and Pina, {Ileana L.} and Lamas, {Gervasio A.} and Kelsey, {Sheryl F.} and Faith Selzer and John Pilotte and Lave, {Judith R.}",
year = "2010",
month = "11",
doi = "10.1016/j.cardfail.2010.05.028",
language = "English (US)",
volume = "16",
pages = "859--866",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "11",

}

TY - JOUR

T1 - Cost of medical services in older patients with heart failure

T2 - Those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: The heart failure home care trial

AU - Soran, Ozlem Z.

AU - Feldman, Arthur M.

AU - Pina, Ileana L.

AU - Lamas, Gervasio A.

AU - Kelsey, Sheryl F.

AU - Selzer, Faith

AU - Pilotte, John

AU - Lave, Judith R.

PY - 2010/11

Y1 - 2010/11

N2 - Background: Prior studies suggest that disease management programs may be effective in improving clinical and economic outcomes in patients with heart failure. Whether these types of programs can lower health care cost and be adapted to the primary care setting is unknown. This study was designed to assess the impact of a home-based disease management program, the Alere DayLink HF Monitoring System (HFMS), on the clinical and economic outcomes of Medicare beneficiaries recently hospitalized for heart failure who received the care from a community-based primary care practitioner. Methods and Results: The Heart Failure Home Care trial was a multicenter, randomized, controlled trial of sophisticated, monitoring of heart failure patients with an interactive program versus standard heart failure care with enhanced patient education and follow-up (SC) in Medicare-eligible patients. The study endpoints included cardiovascular death or rehospitalization for heart failure, length of hospital stay, total patient cost, and cost to Medicare at 6 months of enrollment. A total of 315 patients age ≥65 years old were randomized: 160 to the HFMS and 155 to SC. There were no significant statistical differences between the groups in regards to 6-month cardiac mortality, rehospitalizations for heart failure, or length of hospital stay. Of those, 304 patients had their Medicare data available. The information from the Medicare claims data was used to determine the cost. Information from the trial was used to determine costs of out-patient drugs and the interventions. The 6-month mean Medicare costs were estimated to be $17,837 and $13,886 for the HFMS and the SC groups, respectively. We found that overall medical costs of medicare patients were significantly higher for patients who were randomized to the HFMS arm than they were for the patients randomized to the SC arm. Conclusions: Our study results suggest that enhanced patient education and follow-up is as successful as a sophisticated home monitoring device with an interactive program and less costly in patients who are elderly and receive the care from a community-based primary care practitioner.

AB - Background: Prior studies suggest that disease management programs may be effective in improving clinical and economic outcomes in patients with heart failure. Whether these types of programs can lower health care cost and be adapted to the primary care setting is unknown. This study was designed to assess the impact of a home-based disease management program, the Alere DayLink HF Monitoring System (HFMS), on the clinical and economic outcomes of Medicare beneficiaries recently hospitalized for heart failure who received the care from a community-based primary care practitioner. Methods and Results: The Heart Failure Home Care trial was a multicenter, randomized, controlled trial of sophisticated, monitoring of heart failure patients with an interactive program versus standard heart failure care with enhanced patient education and follow-up (SC) in Medicare-eligible patients. The study endpoints included cardiovascular death or rehospitalization for heart failure, length of hospital stay, total patient cost, and cost to Medicare at 6 months of enrollment. A total of 315 patients age ≥65 years old were randomized: 160 to the HFMS and 155 to SC. There were no significant statistical differences between the groups in regards to 6-month cardiac mortality, rehospitalizations for heart failure, or length of hospital stay. Of those, 304 patients had their Medicare data available. The information from the Medicare claims data was used to determine the cost. Information from the trial was used to determine costs of out-patient drugs and the interventions. The 6-month mean Medicare costs were estimated to be $17,837 and $13,886 for the HFMS and the SC groups, respectively. We found that overall medical costs of medicare patients were significantly higher for patients who were randomized to the HFMS arm than they were for the patients randomized to the SC arm. Conclusions: Our study results suggest that enhanced patient education and follow-up is as successful as a sophisticated home monitoring device with an interactive program and less costly in patients who are elderly and receive the care from a community-based primary care practitioner.

KW - cost

KW - disease management programs

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=78149285499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149285499&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2010.05.028

DO - 10.1016/j.cardfail.2010.05.028

M3 - Article

C2 - 21055649

AN - SCOPUS:78149285499

VL - 16

SP - 859

EP - 866

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 11

ER -